KCM Investment Advisors LLC trimmed its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 665 shares of the semiconductor company’s stock after selling 38 shares during the quarter. KCM Investment Advisors LLC’s holdings in Synopsys were worth $323,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Kieckhefer Group LLC bought a new stake in Synopsys in the 4th quarter valued at about $27,000. Whipplewood Advisors LLC bought a new stake in shares of Synopsys during the fourth quarter valued at approximately $33,000. Sierra Ocean LLC acquired a new position in shares of Synopsys during the fourth quarter worth approximately $39,000. Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock worth $44,000 after purchasing an additional 20 shares in the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC grew its position in Synopsys by 50.8% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 33 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Stock Performance
SNPS opened at $388.13 on Monday. The firm has a market cap of $60.01 billion, a P/E ratio of 26.73, a PEG ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $358.15 and a fifty-two week high of $624.80. The firm has a 50-day moving average of $473.83 and a 200 day moving average of $503.14.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Synopsys
Insider Activity
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Geus Aart De sold 15,705 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the sale, the insider now directly owns 116,671 shares of the company’s stock, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 47,909 shares of company stock valued at $22,794,835 in the last three months. Company insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- CD Calculator: Certificate of Deposit Calculator
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Energy and Oil Stocks Explained
- Disney 2025 Shareholders: Major Updates for Investors
- Buy P&G Now, Before It Sets A New All-Time High
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.